BR112017002474A2 - mistura de ácidos graxos e palmitoiletanolamida para uso no tratamento de patologias alérgicas e inflamatórias - Google Patents
mistura de ácidos graxos e palmitoiletanolamida para uso no tratamento de patologias alérgicas e inflamatóriasInfo
- Publication number
- BR112017002474A2 BR112017002474A2 BR112017002474A BR112017002474A BR112017002474A2 BR 112017002474 A2 BR112017002474 A2 BR 112017002474A2 BR 112017002474 A BR112017002474 A BR 112017002474A BR 112017002474 A BR112017002474 A BR 112017002474A BR 112017002474 A2 BR112017002474 A2 BR 112017002474A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid
- mixture
- palmitoylethanolamide
- allergic
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
a presente invenção refere-se a uma mistura que contém até dois ácidos graxos selecionados a partir de ácido palmítico, ácido oleico, ácido esteárico, ácido linoleico, ácido alfalinolênico, ácido gamalinolênico, ácido eicosapentaenoico, ácido docosa-hexaenoico, ácido azelaico e ácido mirístico e palmitoiletanolamida. em uma modalidade da presente invenção, a dita mistura é distinguida em que pelo menos um dentre os ditos até dois ácidos graxos é saturado. a presente invenção também se refere ao uso da mistura mencionada anteriormente no tratamento de patologias alérgicas e inflamatórias.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20141474 | 2014-08-08 | ||
ITMI2014A001474 | 2014-08-08 | ||
PCT/IB2015/055885 WO2016020828A1 (en) | 2014-08-08 | 2015-08-03 | Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112017002474A2 true BR112017002474A2 (pt) | 2017-12-05 |
BR112017002474B1 BR112017002474B1 (pt) | 2023-09-19 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
TWI727926B (zh) | 2021-05-21 |
JP2017523230A (ja) | 2017-08-17 |
CA2957700C (en) | 2022-12-13 |
MA40417A (fr) | 2017-06-14 |
US20170224645A1 (en) | 2017-08-10 |
JP7335475B2 (ja) | 2023-08-30 |
DK3177281T3 (da) | 2024-03-11 |
CA2957700A1 (en) | 2016-02-11 |
JP2021004260A (ja) | 2021-01-14 |
WO2016020828A1 (en) | 2016-02-11 |
FI3177281T3 (fi) | 2024-03-13 |
IL250271B (en) | 2022-10-01 |
TW201609084A (zh) | 2016-03-16 |
EP3177281A1 (en) | 2017-06-14 |
US20180243254A1 (en) | 2018-08-30 |
CN106714792A (zh) | 2017-05-24 |
JP2023041806A (ja) | 2023-03-24 |
IL250271A0 (en) | 2017-03-30 |
EP3177281B1 (en) | 2023-12-06 |
US10149827B2 (en) | 2018-12-11 |
US9962355B2 (en) | 2018-05-08 |
JP7118642B2 (ja) | 2022-08-16 |
IL250271B2 (en) | 2023-02-01 |
CO2017001088A2 (es) | 2017-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019003105A1 (es) | Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560) | |
CO2017001088A2 (es) | Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas | |
ZA201704820B (en) | Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids | |
MY165048A (en) | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | |
BR112017013445A2 (pt) | processo para aumentar a estabilidade de uma composição que compreende ácidos graxos ômega 6 poli-insaturados | |
CY1122248T1 (el) | Μιγμα λιπαρων οξεων προς χρηση στη θεραπευτικη αγωγη φλεγμονωδων παθολογιων | |
AR101192A1 (es) | Composición nutricional que contiene mezclas de aceites y método de promoción de la digestión de grasas y lípidos | |
SG11201604775TA (en) | Composition comprising esters of lignin and oil or fatty acids | |
BR112018003578A2 (pt) | composições de óleo refinado e métodos para fazer | |
AR105190A1 (es) | Composiciones nutricionales y métodos para promover el desarrollo cognitivo | |
BR112018077500A2 (pt) | alimento animal que compreende uma composição de ácido graxo poli-insaturado ômega-3 | |
BR112016025931A8 (pt) | composição de barra de sabão extrudada, barra e método para intensificar a transparência das barras de sabão | |
BR112014017048A2 (pt) | emulsão orgânica compreendendo dha e epa | |
BR112016028561A8 (pt) | composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas | |
BR112015008195A2 (pt) | composição de triglicerídeos e dispositivo elétrico | |
GB201611503D0 (en) | Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids | |
MY182731A (en) | Fat composition | |
AR116761A2 (es) | Lípido que comprende ácidos grasos poliinsaturados de cadena larga | |
GB201607617D0 (en) | Use of EPA and DHA Omega3 Dietary supplementation and Omega6 polyunsaturated fatty acid dietary restriction to cure 2 type diabetes | |
GB201611499D0 (en) | Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids | |
GB201611500D0 (en) | Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids | |
AR095832A1 (es) | Composición farmacéutica oral útil para el trastorno del déficit de atención e hiperactividad, suplemento nutricional y alimento que la comprenden y proceso para preparar la composición | |
GB201611505D0 (en) | A composition for enriching animal meat with Omega 3 polyunsaturated fatty acids | |
DE112016002109A5 (de) | Anwendung von Omega-3- und/oder Omega-6-Fettsäure(n) | |
UA90903U (uk) | Спосіб оцінки ефективності використання ірбесартану в комбінації з лізинієм при експериментальній артеріальній гіпертензії |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ALI RESEARCH SRLS (IT) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/08/2015, OBSERVADAS AS CONDICOES LEGAIS |